Pharma: Structural Reform and Platform Development to Grow Income from Overseas Agricultural Chemicals and Veterinary Drug Business

Meiji Holdings Co., Ltd. Financial Results for FYE March 2018and New Medium-term Business Plan

	TOP

	Financial Results for FYE March 2018 and New Medium-term Business Plan

	Agenda

	1. Overview of STEP UP 17

	2. The Meiji Group 2026 Vision

	3. The New Medium-term Business Plan Key Strategies Food: Expanding Yogurt, Chocolate, and Nutritional Products Food: Cultivate Future Growth Drivers Pharma: Maximize Product Value in Core Domains and Enhance Presence Pharma: Expand Sales of Generic Drugs and Accelerate Biosimilar Development to Drive Growth Food: Launch High Value-added Products, Invest Intensely in Overseas Business Pharma: Expand CMO/CDMO Business at Medreich Food: Continue Structural Reforms to Improve Productivity Food: Improve Profitability in Milk Business Pharma: Structural Reform and Platform Development to Grow Income from Overseas Agricultural Chemicals and Veterinary Drug Business KPIs - The New Medium-term Business Plan (1) KPIs - The New Medium-term Business Plan (2) Use of Cash Flows

	4. Outlook for the FYE March 2019

	Appendix: Financial data

	Appendix: Topics

	Back cover

Pharma: Structural Reform and Platform Development to Grow Income from Overseas Agricultural Chemicals and Veterinary Drug Business

Prev. Page

Next Page

Download the PDF

Pharmaceutical segment
Make agricultural chemicals and veterinary drugs business profitable
Agricultural chemicals

• Discovered three products in pipeline in our research lab

• Licensing them out to global companies

• Get royalty income and expand export of active ingredient

• Promote research of new products aiming for global development

Only 40 agricultural chemicals in late-stage development globally
Of those, 12 belong to major corporations such as Bayer, DuPont, and Dow Chemicals.
We have strong R&D capability